vimarsana.com

Adults and adolescents with moderate to severe AD treated with lebrikizumab reported improvements in itch and sleep interference.

Related Keywords

United Kingdom ,British , ,British Journal ,Pruritus Numeric Rating Scale ,Sleep Loss Scale ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.